Take a deeper dive

Webinar | Pediatric Drug Development: Allometry and Other Empirical Models

This webinar covers an introduction of pediatric drug development using allometric scaling and other empirical models. Other empirical models will include Physiologically-Based Pharmacokinetics (PBPK) and Population PK (popPK).

At the end of this webinar attendees should have a better understanding of:

  • Allometry and its appropriate application to pediatric drug development
  • Simplicity of allometric scaling in comparison to other complex empirical models
  • Dose selection for first-in-pediatric clinical trials

Meet the Speaker

Iftekhar Mahmood, Ph.D.
Senior Consultant, Clinical Pharmacology and Pharmacometrics

Dr. Mahmood has more than 25 years of experience in clinical pharmacology with the FDA. He worked both in the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). At the FDA, besides his review duties, Dr. Mahmood was involved with clinical pharmacology research (both small and large molecules) and published more than 100 research papers in peer-reviewed scientific journals. His research mainly focused on allometric scaling, modeling, sparse sampling, and pediatric drug development.

Explore Our Blog

Pre-IND Meeting Guide: Benefits & How to Prepare

Regulatory guidelines allow for formal meetings between the FDA and sponsors or applicants to discuss the development and review of…

Read More

When Should You Hire a Clinical Pharmacologist?

Because of the importance of clinical pharmacology to drug development, it is essential to consider the expertise of your product…

Read More

What is a 505(b)(2)?

The 505(b)(2) New Drug Application (NDA) is a streamlined NDA process in which the applicant relies upon one or more…

Read More